Psilocybin rTMS for Treatment Resistant Depression — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Psilocybin rTMS for Treatment Resistant Depression — Stella

Home/Treatment Resistant Depression/

View on ClinicalTrials.gov

Recruiting

Back to Treatment Resistant Depression trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Health Discovery Building (HDB), 1601 Trinity St., Bldg B., Z0600, Austin, Texas

Key details

Phase

Safety & dosing

Sponsor

University of Texas at Austin

Enrollment target

~100 participants

Started

January 2025

Primary completion

December 2029

Age range

22 Years – 65 Years

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.